NUVB - Nuvation Bio Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.00
DETAILS
HIGH:
$17.00
LOW:
$10.00
MEDIAN:
$12.50
CONSENSUS:
$13.00
UPSIDE:
175.42%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 4,539,800 | $19.5M | 0.6% | +4,539,800 | NEW |
| Cooperman | 392,986 | $1.7M | 0.0% | -482,816 | DECREASED |
| Greenblatt | 0 | $0 | -- | -31,269 | SOLD |
| Wood | 0 | $0 | -- | -19,588 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-17 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | M-Exempt | 50,000 | $1.94 | $97K |
| 2026-04-17 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | SELL | 50,000 | $5.02 | $251K |
| 2026-04-17 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | SELL | 36,750 | $5.01 | $184K |
| 2026-04-17 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | M-Exempt | 36,750 | $2.93 | $108K |
| 2026-04-06 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | M-Exempt | 100,000 | $1.87 | $187K |
| 2026-04-06 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | SELL | 200,000 | $4.52 | $904K |
| 2026-02-27 | Sjogren Colleen | officer: Chief Commercial Officer | A-Award | 748,130 | $5.91 | $4.4M |
| 2026-02-27 | Hanley David C. | officer: CHIEF TECHNICAL OPERATIONS | A-Award | 748,130 | $5.91 | $4.4M |
| 2026-02-27 | Hung David | director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | 1,995,012 | $5.91 | $11.8M |
| 2026-02-27 | Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | A-Award | 748,130 | $5.91 | $4.4M |
| 2026-02-27 | Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | A-Award | 748,130 | $5.91 | $4.4M |
| 2026-02-27 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | A-Award | 748,130 | $5.91 | $4.4M |
| 2026-02-27 | Makunje Moses | officer: SEE REMARKS | A-Award | 224,439 | $5.91 | $1.3M |
| 2026-02-27 | Makunje Moses | officer: SEE REMARKS | A-Award | 50,761 | -- | -- |
| 2026-02-27 | Cui Xiangmin | director | A-Award | 74,813 | $5.91 | $442K |
| 2026-02-27 | Sauvage Philippe | officer: Chief Financial Officer | A-Award | 748,130 | $5.91 | $4.4M |
| 2026-02-27 | Markel Stacy | officer: CHIEF PEOPLE OFFICER | A-Award | 748,130 | $5.91 | $4.4M |
| 2025-12-01 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | SELL | 150,000 | $7.82 | $1.2M |
| 2025-12-01 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | M-Exempt | 150,000 | $2.93 | $440K |
| 2025-11-26 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | SELL | 10,000 | $8.00 | $80K |
| 2025-11-26 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10,000 | $3.61 | $36K |
| 2025-11-25 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | SELL | 10,000 | $7.50 | $75K |
| 2025-11-25 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10,000 | $3.61 | $36K |
| 2025-11-20 | Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | M-Exempt | 69,051 | $1.74 | $120K |
| 2025-11-20 | Liu Dongfang | officer: CHIEF MEDICAL OFFICER | M-Exempt | 20,000 | $1.87 | $37K |